expert roundtables

Risk Stratification in Myelofibrosis
Oncology

Risk Stratification in Myelofibrosis

expert roundtables
By Aaron T. Gerds, MD, MS; Stephen T. Oh, MD, PhD; Raajit K. Rampal, MD, PhD
Expert Roundtables Podcast: Defining the Needs of Today’s Patients With Relapsed/Refractory Multiple Myeloma
Oncology

Expert Roundtables Podcast: Defining the Needs of Today’s Patients With Relapsed/Refractory Multiple Myeloma

expert roundtables
By David E. Avigan, MD; Irene M. Ghobrial, MD; Saad Z. Usmani, MBBS, MD, MBA, FACP, FRCP, FASCO
Toxicity-Sparing Strategies and Supportive Care in Relapsed Multiple Myeloma
Oncology

Toxicity-Sparing Strategies and Supportive Care in Relapsed Multiple Myeloma

expert roundtables
By David E. Avigan, MD; Irene M. Ghobrial, MD; Saad Z. Usmani, MBBS, MD, MBA, FACP, FRCP, FASCO
Novel Combination Therapies for High-Risk Mantle Cell Lymphoma
Oncology

Novel Combination Therapies for High-Risk Mantle Cell Lymphoma

expert roundtables
By Preetesh Jain, MBBS, MD, DM, PhD; Bijal Shah, MD, MS; Michael Wang, MD
Novel Insights Into Plaque Psoriasis Biomarkers for Guiding Prognosis and Therapy
Dermatology

Novel Insights Into Plaque Psoriasis Biomarkers for Guiding Prognosis and Therapy

expert roundtables
By Jeffrey M. Cohen, MD, MPH; Adam Friedman, MD, FAAD; Joel M. Gelfand, MD, MSCE
Load More